pfizer glp-1 agonist glp 1 While Lilly and Novo dominate today's $50B+ obesity market, is preparing a killer portfolio to steal the spotlight in 2030s Pfizer targets obesity with new – In the same week that
Pay in 4 interest-free payments of $5.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



























